|
[Related PubMed/MEDLINE] Total Number of Papers: 10
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: MAF |
Long Form |
: mafosfamide |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2000 |
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma. |
4-HC, ASCT |
2 |
1999 |
Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine. |
4-HC, B-CLL, CdA, CP |
3 |
1998 |
Dependence of aldehyde dehydrogenase-mediated oxazaphosphorine resistance on soluble thiols: importance of thiol interactions with the secondary metabolite acrolein. |
4-hpCPA, MESNA, OAP |
4 |
1996 |
In vitro pharmalogic rationale for intraperitoneal regional chemotherapy. |
5-FU, 5-FUDR, EPI, HTCA, MMC, VDS |
5 |
1995 |
Activated lymphocytes in the marrow cell suspension decrease the mafosfamide-induced CFU-GM cytotoxicity. |
AML, CLL |
6 |
1995 |
Drug combination testing in acute lymphoblastic leukemia using the MTT assay. |
ALL, DNR, PRD, VCR |
7 |
1993 |
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. |
ALL, DNR, L-ASP, PRED |
8 |
1993 |
Chemosensitisation of alkylating agents by pentoxifylline, O6-benzylguanine and ethacrynic acid in haematological malignancies. |
AML, BCNU, CLL, EA, GST, O6-BG, PTX, RM |
9 |
1991 |
In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. |
BM, PB |
10 |
1987 |
Preclinical and early clinical trial with mafosfamide as immune modulator. |
CPA, EAT |
|